Conferring receptors on recipient cells with extracellular vesicles for targeted drug delivery
Triple negative breast cancer (TNBC) is a heterogeneous subset of breast cancer characterized by its lack of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2), which altogether prevents TNBC from being treated effectively. For many years, the treatment par...
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
KeAi Communications Co., Ltd.
2021-03-01
|
| Collection: | Bioactive Materials |
| Sujets: | |
| Accès en ligne: | http://www.sciencedirect.com/science/article/pii/S2452199X20302358 |